Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs.

FORMAL SB, DAMMIN GJ, LABREC EH, SCHNEIDER H.

J Bacteriol. 1958 May;75(5):604-10. No abstract available.

2.

Experimental keratoconjunctivitis shigellosa.

SERENY B.

Acta Microbiol Acad Sci Hung. 1957;4(4):367-76. No abstract available.

PMID:
13508157
4.
5.

Shigella subversion of the cellular cytoskeleton: a strategy for epithelial colonization.

Goldberg MB, Sansonetti PJ.

Infect Immun. 1993 Dec;61(12):4941-6. Review. No abstract available.

7.

A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Tsai CM, Frasch CE.

Anal Biochem. 1982 Jan 1;119(1):115-9. No abstract available.

PMID:
6176137
8.

Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.

Mel DM, Arsić BL, Nikolić BD, Radovanić ML.

Bull World Health Organ. 1968;39(3):375-80.

9.

Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.

Mel D, Gangarosa EJ, Radovanovic ML, Arsic BL, Litvinjenko S.

Bull World Health Organ. 1971;45(4):457-64.

10.

Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.

Mel DM, Arsic BL, Radovanovic ML, Litvinjenko SA.

Acta Microbiol Acad Sci Hung. 1974;21(1-2):109-14. No abstract available.

PMID:
4613128
11.

Identification of gram-negative aerobic fermentors in a clinical bacteriological laboratory.

Lindberg AA, Nord CE, Hellgren M, Sjöberg L.

Med Microbiol Immunol. 1974 Mar 22;159(3):201-10. No abstract available.

PMID:
4598392
12.

Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.

Levine MM, Gangarosa EJ, Werner M, Morris GK.

J Pediatr. 1974 Jun;84(6):803-6. No abstract available.

PMID:
4596999
13.

Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.

Levine MM, Dupont HL, Gangarosa EJ, Hornick RB, Snyder MJ, Libonati JP, Glaser K, Formal SB.

Am J Epidemiol. 1972 Jul;96(1):40-9. No abstract available.

PMID:
4557072
14.

Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.

DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJ.

J Infect Dis. 1972 Jan;125(1):12-6. No abstract available.

PMID:
4550416
15.

Plaque formation by virulent Shigella flexneri.

Oaks EV, Wingfield ME, Formal SB.

Infect Immun. 1985 Apr;48(1):124-9.

16.
17.

A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a.

Makino S, Sasakawa C, Kamata K, Kurata T, Yoshikawa M.

Cell. 1986 Aug 15;46(4):551-5.

PMID:
3524856
18.

Development of an auxotrophic oral live Shigella flexneri vaccine.

Lindberg AA, Kärnell A, Stocker BA, Katakura S, Sweiha H, Reinholt FP.

Vaccine. 1988 Apr;6(2):146-50. Review.

PMID:
2838986
Items per page

Supplemental Content

Write to the Help Desk